Company profile
Polyphotonix Limited
PolyPhotonix Improving the quality of life through the application of science
Polyphotonix Limited is a UK company with status active founded in 2008 based in North East England.
Corporate ownership
Updated 06 Jun 2026 16:52
Latest accounts
Financial period: 1 Apr 2023 to 31 Mar 2024
Company events
Reference milestones and recent Companies House filing stream events.
Confirmation statement due
Confirmation DueNext confirmation statement due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts due
Accounts DueNext accounts due date
Change Registered Office Address Company With Date Old Address New Address
AddressAD01 | Transaction MzQzNzIyNDA3MGFkaXF6a2N4
Published 25 Sep 2024 03:58
Accounts filed
AccountsLast accounts made up date
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Real-world Evaluation of Noctura 400 sleep mask for DiabEtic Retinopathy (RENDER)
1 Aug 2019 to 31 Oct 2020
The Noctura 400 Sleep Mask is a novel and innovative treatment for Diabetic Retinopathy and Diabetic Macular Oedema, which are the serious and sight threatening complications of Diabetes. The mask offers a completely new approach to treatment of these conditions as it delivers a low level of light into the eye while the patient sleeps. It is non-invasive ...
flexible Light EmittinG ElectroNics - Development of materials and process (LEGEND)
1 Sep 2017 to 31 Oct 2018
Processes will be developed to produce a quantum dot based frequency modifying system for flexible light emitting sheets. New silicon based light emitting diodes will be developed with integral beam shaping and driving logic that will be integrated into a number of flexible substrates with emission spectra tailored to be compatible with the absorption cur...
Production line Readines for light EMItting ElectRochemical cells (PREMIER)
1 Jul 2015 to 31 Mar 2016
PolyPhotonix Limited and the Centre for Process Innovation have developed novel light emissive devices that can be used in Fast Moving Consumer Goods such as greetings cards, Christmas decorations and advertising. They can also be used in medical applications for areas such as neonatal/postnatal jaundice, in wound healing and for cosmetic applications. Th...
onic liquid based Screen Print INk DeveLopment for printed Electronics (SPINDLE)
1 Jun 2015 to 30 Sep 2015
PolyPhotonix is developing technology for printed electronics via a roll to roll printing technique. In order to allow PolyPhotonix's medical, point of sale or advertising light emitting devices to be manufactured in sufficient quantities, rotary screen printing is required. The commercially available inks that are currently available are not fit for purp...
a novel SystEm for the Manufacturing of PRinted Electronics (SEMPRE)
1 May 2015 to 30 Apr 2016
PolyPhotonix Limited will design and build a bench top deposition tool that can manufacture flexible printed electronic devices using a novel material deposition method. The tool will be a pseudo roll to roll manufacturing tool which will simulate deposition processes occurring in a full scale roll to roll manufacturing process. This tool that PolyPhotoni...
GraphTED - Graphene as a Transparent Electrode in Organic Electronic Devices
1 Apr 2015 to 31 Mar 2016
The partners will use graphene to develop novel ink formulations that can be used within printed electronic devices. The properties of the graphene layers deposited will be characterised in detail along with the properties of the printed electronic devices manufactured.
combining Printed Electronics And Conventional Electronics to simplify production of a phototherapy device (PEACE)
1 Jan 2015 to 31 Dec 2016
The project partners will integrate printed electronics (PE) and conventional (CE) solid state electronics in order to improve functionality, reduce cost and increase scalability of a photonics based medical device. New methods will be employed in order to produce luminaires, printed sensors and PE/PE or PE/CE interconnects. These will be combined with co...
the manufacture of a flexiBle blAnket that will provide phototherapy treatMent for a numBer Of cOnditions (BAMBOO)
1 Aug 2014 to 31 Jul 2015
Project BAMBOO will develop a wearable and flexible phototherapy device for the treatment of a number of medical conditions including but not limited to wound healing, neonatal hyperbilirubinia or Psoresis. The device will be produced by printing methods it will incorporate sensors to allow the measurement of disease progression, monitor infection and man...
The University of Liverpool and Polyphotonix Limited
1 May 2014 to 30 Apr 2016
To embed capabilities to design, produce and certify medical diagnostic instruments based on OLED technologies to clinically assess patients with eye disorders eg retinal pathologies.
feasibiLity of rapId modification of liGht emitting electrocHemical cell formulaTions to produce emission spectra on demand (LIGHT)
1 Mar 2014 to 30 Nov 2014
In this feasibility study, the ability to rapidly produce light emitting organic formulations with a tailored or bespoke emission spectra through intermixing of various emitter species will be undertaken. Instead of manufacturing long chain, multi-functional group, electroluminescent polymers with a complex, slow and expensive synthesis path, we will stud...
POLYPHOTONIX NOCTURA 500 MEDICAL DEVICE DEVELOPMENT
1 Nov 2013 to 30 Apr 2015
PolyPhotonix Ltd, an innovative UK SME, based in the North East of England will develop a prototype light therapy sleep mask "Noctura 500" for the treatment of wet age related macular degeneration (Wet AMD). The Noctura 500 concept results from earlier in-house R&D activities in the area of Organic Light Emitting Diode (OLED) technology. Through cooperati...
feaSibility studies for a phototherapy Mask to treAt dry aGe related Macular degenerAtion (MAGMA)
1 Oct 2013 to 30 Sep 2014
Polyphotonix is working with University College London to understand how the delivery of photonic treatments to the eyes can treat the condition known as Dry Age Related Macular Degeneration. In this project a feasibility study will be carried out in order to define the dose required for efficatious treatment of the condition and also a delivery method wi...